| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Calcitriol | 31 | 2016 | 130 | 6.910 |
Why?
|
| Vitamin D | 20 | 2016 | 285 | 3.690 |
Why?
|
| Renin-Angiotensin System | 18 | 2015 | 87 | 3.680 |
Why?
|
| Calcitriol | 13 | 2013 | 173 | 2.590 |
Why?
|
| Diabetic Nephropathies | 9 | 2017 | 93 | 2.210 |
Why?
|
| Signal Transduction | 16 | 2017 | 3615 | 1.640 |
Why?
|
| Gene Expression Regulation | 17 | 2015 | 2022 | 1.480 |
Why?
|
| Renin | 11 | 2012 | 68 | 1.480 |
Why?
|
| Podocytes | 6 | 2013 | 35 | 1.310 |
Why?
|
| NF-kappa B | 9 | 2017 | 423 | 1.270 |
Why?
|
| Intestinal Mucosa | 7 | 2015 | 834 | 1.240 |
Why?
|
| Vitamins | 5 | 2010 | 93 | 1.200 |
Why?
|
| Mice | 42 | 2017 | 12682 | 1.070 |
Why?
|
| Epithelial Cells | 8 | 2015 | 707 | 1.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 4 | 2010 | 46 | 0.950 |
Why?
|
| Kidney | 8 | 2017 | 1123 | 0.920 |
Why?
|
| Losartan | 7 | 2010 | 29 | 0.900 |
Why?
|
| Kidney Diseases | 4 | 2013 | 314 | 0.890 |
Why?
|
| Animals | 51 | 2017 | 28864 | 0.890 |
Why?
|
| Hyperglycemia | 3 | 2017 | 186 | 0.860 |
Why?
|
| Mesangial Cells | 2 | 2017 | 9 | 0.810 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2017 | 207 | 0.790 |
Why?
|
| Inflammation | 7 | 2015 | 1118 | 0.790 |
Why?
|
| Colitis | 6 | 2015 | 264 | 0.780 |
Why?
|
| Mice, Knockout | 16 | 2015 | 2206 | 0.780 |
Why?
|
| MicroRNAs | 5 | 2016 | 603 | 0.750 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 588 | 0.720 |
Why?
|
| Cyclic AMP | 2 | 2017 | 277 | 0.720 |
Why?
|
| Ergocalciferols | 3 | 2010 | 38 | 0.670 |
Why?
|
| Vitamin D Deficiency | 5 | 2013 | 119 | 0.640 |
Why?
|
| Glucose | 2 | 2017 | 703 | 0.630 |
Why?
|
| Promoter Regions, Genetic | 8 | 2017 | 976 | 0.600 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2015 | 677 | 0.570 |
Why?
|
| Energy Metabolism | 2 | 2011 | 312 | 0.540 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2017 | 7 | 0.520 |
Why?
|
| Histones | 2 | 2017 | 369 | 0.500 |
Why?
|
| Albuminuria | 3 | 2016 | 53 | 0.500 |
Why?
|
| Calcium | 8 | 2016 | 1195 | 0.500 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 64 | 0.500 |
Why?
|
| Macrophages | 4 | 2013 | 641 | 0.490 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2013 | 20 | 0.490 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 119 | 0.480 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2015 | 8 | 0.470 |
Why?
|
| Homeostasis | 6 | 2015 | 474 | 0.460 |
Why?
|
| Cardiovascular Diseases | 2 | 2013 | 802 | 0.450 |
Why?
|
| S100 Calcium Binding Protein G | 2 | 2005 | 19 | 0.440 |
Why?
|
| Adipocytes | 3 | 2011 | 177 | 0.440 |
Why?
|
| Interleukin-18 | 2 | 2006 | 27 | 0.420 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 412 | 0.420 |
Why?
|
| Interleukin-10 | 1 | 2015 | 167 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 11 | 2015 | 3591 | 0.420 |
Why?
|
| Receptor, TIE-2 | 1 | 2013 | 20 | 0.400 |
Why?
|
| Angiopoietin-2 | 1 | 2013 | 23 | 0.400 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 158 | 0.390 |
Why?
|
| Keratinocytes | 2 | 2006 | 156 | 0.390 |
Why?
|
| Kidney Glomerulus | 2 | 2013 | 121 | 0.390 |
Why?
|
| Antihypertensive Agents | 4 | 2012 | 267 | 0.390 |
Why?
|
| Blood Pressure | 3 | 2007 | 910 | 0.380 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 73 | 0.380 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 198 | 0.380 |
Why?
|
| Angiotensin II | 5 | 2015 | 98 | 0.370 |
Why?
|
| Atherosclerosis | 2 | 2013 | 266 | 0.370 |
Why?
|
| Angiotensinogen | 2 | 2009 | 5 | 0.370 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 1604 | 0.370 |
Why?
|
| Receptors, LDL | 1 | 2012 | 54 | 0.360 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 106 | 0.360 |
Why?
|
| Vitamin D Response Element | 1 | 2011 | 1 | 0.350 |
Why?
|
| Juxtaglomerular Apparatus | 2 | 2008 | 2 | 0.340 |
Why?
|
| Hypertension | 5 | 2015 | 778 | 0.340 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 53 | 0.330 |
Why?
|
| Inflammation Mediators | 4 | 2013 | 164 | 0.330 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 46 | 0.330 |
Why?
|
| Fatty Acids | 1 | 2011 | 147 | 0.320 |
Why?
|
| Colon | 4 | 2015 | 561 | 0.310 |
Why?
|
| Membrane Proteins | 3 | 2012 | 1285 | 0.310 |
Why?
|
| Fibroblasts | 3 | 2010 | 767 | 0.300 |
Why?
|
| Immunity, Innate | 1 | 2013 | 481 | 0.300 |
Why?
|
| Alopecia | 2 | 2016 | 36 | 0.300 |
Why?
|
| Hair Follicle | 2 | 2016 | 29 | 0.300 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 269 | 0.300 |
Why?
|
| Protective Agents | 1 | 2009 | 34 | 0.290 |
Why?
|
| Up-Regulation | 5 | 2017 | 743 | 0.290 |
Why?
|
| Polyuria | 1 | 2008 | 7 | 0.290 |
Why?
|
| Thirst | 1 | 2008 | 19 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2015 | 707 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 1286 | 0.280 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 131 | 0.270 |
Why?
|
| Humans | 34 | 2016 | 97913 | 0.270 |
Why?
|
| Cells, Cultured | 7 | 2016 | 2854 | 0.260 |
Why?
|
| RNA, Messenger | 8 | 2014 | 2060 | 0.260 |
Why?
|
| Models, Biological | 5 | 2013 | 1809 | 0.260 |
Why?
|
| Fibrosis | 3 | 2017 | 234 | 0.250 |
Why?
|
| Ion Channels | 1 | 2009 | 259 | 0.250 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 98 | 0.250 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 312 | 0.250 |
Why?
|
| Captopril | 2 | 2004 | 22 | 0.250 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 642 | 0.250 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2006 | 14 | 0.240 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 31 | 0.240 |
Why?
|
| I-kappa B Proteins | 1 | 2006 | 47 | 0.240 |
Why?
|
| Interleukin-1 | 1 | 2006 | 72 | 0.240 |
Why?
|
| Cell Line | 5 | 2013 | 2482 | 0.220 |
Why?
|
| Calcium, Dietary | 1 | 2005 | 69 | 0.220 |
Why?
|
| Cell Line, Transformed | 2 | 2017 | 153 | 0.210 |
Why?
|
| Sulfates | 1 | 2004 | 38 | 0.210 |
Why?
|
| Gene Expression | 6 | 2009 | 1320 | 0.210 |
Why?
|
| Acetylation | 2 | 2017 | 151 | 0.210 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2017 | 16 | 0.210 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2017 | 80 | 0.210 |
Why?
|
| Disease Progression | 3 | 2015 | 1607 | 0.210 |
Why?
|
| Obesity | 1 | 2011 | 1058 | 0.210 |
Why?
|
| Apoptosis | 4 | 2015 | 1750 | 0.200 |
Why?
|
| Cardiomegaly | 1 | 2004 | 114 | 0.200 |
Why?
|
| Cation Transport Proteins | 1 | 2004 | 65 | 0.200 |
Why?
|
| Fibronectins | 2 | 2017 | 104 | 0.200 |
Why?
|
| Symporters | 1 | 2004 | 116 | 0.200 |
Why?
|
| RNA Interference | 3 | 2017 | 388 | 0.190 |
Why?
|
| Time Factors | 5 | 2017 | 5566 | 0.190 |
Why?
|
| Dextran Sulfate | 3 | 2014 | 71 | 0.190 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2003 | 41 | 0.190 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 550 | 0.190 |
Why?
|
| Mice, Inbred DBA | 2 | 2012 | 146 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 889 | 0.160 |
Why?
|
| Fumarates | 2 | 2012 | 20 | 0.160 |
Why?
|
| Amides | 2 | 2012 | 54 | 0.160 |
Why?
|
| HCT116 Cells | 3 | 2015 | 163 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2017 | 1145 | 0.150 |
Why?
|
| Tight Junctions | 2 | 2013 | 158 | 0.150 |
Why?
|
| DNA, Complementary | 3 | 2004 | 380 | 0.150 |
Why?
|
| Cytokines | 3 | 2015 | 889 | 0.150 |
Why?
|
| Drug Synergism | 2 | 2010 | 317 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 419 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2010 | 2570 | 0.140 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2009 | 78 | 0.140 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2009 | 23 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2015 | 613 | 0.140 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 217 | 0.130 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 764 | 0.130 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2017 | 12 | 0.130 |
Why?
|
| Acetyl Coenzyme A | 1 | 2017 | 14 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2013 | 678 | 0.130 |
Why?
|
| Collagen Type IV | 1 | 2017 | 28 | 0.130 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2015 | 16 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 1566 | 0.130 |
Why?
|
| Citric Acid | 1 | 2017 | 47 | 0.130 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 582 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 92 | 0.120 |
Why?
|
| Thioctic Acid | 1 | 2016 | 2 | 0.120 |
Why?
|
| Finasteride | 1 | 2016 | 8 | 0.120 |
Why?
|
| Salts | 2 | 2008 | 18 | 0.120 |
Why?
|
| Carnitine | 1 | 2016 | 14 | 0.120 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2016 | 12 | 0.120 |
Why?
|
| Sterols | 1 | 2016 | 19 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 213 | 0.120 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2015 | 41 | 0.110 |
Why?
|
| Endocrine System | 2 | 2015 | 16 | 0.110 |
Why?
|
| Parathyroid Hormone | 2 | 2008 | 233 | 0.110 |
Why?
|
| Transfection | 1 | 2017 | 883 | 0.110 |
Why?
|
| Androgens | 1 | 2016 | 164 | 0.110 |
Why?
|
| Calbindins | 2 | 2005 | 16 | 0.110 |
Why?
|
| DNA Primers | 3 | 2008 | 530 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2015 | 30 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 76 | 0.110 |
Why?
|
| Phytotherapy | 1 | 2016 | 139 | 0.110 |
Why?
|
| Prostatic Hyperplasia | 1 | 2016 | 104 | 0.110 |
Why?
|
| Base Sequence | 2 | 2010 | 2222 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2016 | 529 | 0.100 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2013 | 6 | 0.100 |
Why?
|
| Steroid Hydroxylases | 1 | 2013 | 13 | 0.100 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 136 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2013 | 7 | 0.100 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 25 | 0.100 |
Why?
|
| Water-Electrolyte Balance | 2 | 2003 | 71 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2013 | 133 | 0.100 |
Why?
|
| Male | 10 | 2016 | 46983 | 0.100 |
Why?
|
| Proteinuria | 1 | 2013 | 72 | 0.100 |
Why?
|
| Bone and Bones | 2 | 2004 | 270 | 0.100 |
Why?
|
| Caco-2 Cells | 2 | 2015 | 128 | 0.090 |
Why?
|
| Permeability | 2 | 2015 | 145 | 0.090 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2013 | 73 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 71 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 201 | 0.090 |
Why?
|
| Rats | 3 | 2015 | 4071 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2013 | 353 | 0.090 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 105 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 293 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 749 | 0.090 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 2 | 2009 | 33 | 0.090 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Lipolysis | 1 | 2011 | 24 | 0.090 |
Why?
|
| Intestines | 1 | 2015 | 441 | 0.090 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 25 | 0.090 |
Why?
|
| Retinoid X Receptors | 1 | 2011 | 38 | 0.090 |
Why?
|
| Biological Transport, Active | 1 | 2011 | 98 | 0.090 |
Why?
|
| Phenotype | 2 | 2011 | 2638 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 311 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 184 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2013 | 166 | 0.080 |
Why?
|
| RNA Polymerase II | 1 | 2011 | 63 | 0.080 |
Why?
|
| Thermogenesis | 1 | 2011 | 47 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 395 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 269 | 0.080 |
Why?
|
| Kidney Tubules | 1 | 2011 | 91 | 0.080 |
Why?
|
| Aorta | 1 | 2012 | 275 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2011 | 287 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 402 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 198 | 0.080 |
Why?
|
| Angiotensin I | 1 | 2010 | 8 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2013 | 500 | 0.080 |
Why?
|
| Lipids | 1 | 2012 | 293 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 33 | 0.080 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 34 | 0.080 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 45 | 0.080 |
Why?
|
| Cholesterol | 1 | 2012 | 373 | 0.080 |
Why?
|
| Locomotion | 1 | 2011 | 148 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2013 | 357 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2010 | 75 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 660 | 0.080 |
Why?
|
| Glomerular Basement Membrane | 1 | 2009 | 5 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 114 | 0.070 |
Why?
|
| Uncoupling Protein 3 | 1 | 2009 | 9 | 0.070 |
Why?
|
| Uncoupling Protein 2 | 1 | 2009 | 11 | 0.070 |
Why?
|
| Creatinine | 1 | 2010 | 312 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 564 | 0.070 |
Why?
|
| Uncoupling Protein 1 | 1 | 2009 | 44 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 720 | 0.070 |
Why?
|
| RNA | 2 | 2004 | 593 | 0.070 |
Why?
|
| Female | 8 | 2016 | 51441 | 0.070 |
Why?
|
| Prevalence | 1 | 2013 | 1381 | 0.070 |
Why?
|
| Streptozocin | 1 | 2008 | 57 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1644 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2008 | 66 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2009 | 239 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 565 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2008 | 201 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2008 | 7 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1133 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 1101 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 238 | 0.070 |
Why?
|
| Sodium | 1 | 2009 | 330 | 0.070 |
Why?
|
| Ulcer | 1 | 2007 | 38 | 0.070 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2007 | 22 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 356 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 220 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 726 | 0.060 |
Why?
|
| Cholecalciferol | 1 | 2007 | 37 | 0.060 |
Why?
|
| Response Elements | 1 | 2007 | 68 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2007 | 118 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 2010 | 0.060 |
Why?
|
| Drug Design | 1 | 2007 | 135 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2007 | 305 | 0.060 |
Why?
|
| Lung | 1 | 2013 | 1403 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2006 | 19 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 445 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2006 | 38 | 0.060 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2006 | 15 | 0.060 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2006 | 37 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 291 | 0.060 |
Why?
|
| Ligands | 1 | 2007 | 486 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 731 | 0.060 |
Why?
|
| Antibodies | 1 | 2007 | 349 | 0.060 |
Why?
|
| RNA Stability | 1 | 2006 | 98 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2006 | 282 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2012 | 843 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1946 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 1324 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 687 | 0.060 |
Why?
|
| Wound Healing | 1 | 2007 | 384 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2012 | 824 | 0.050 |
Why?
|
| Pregnancy | 1 | 2012 | 3243 | 0.050 |
Why?
|
| Rickets | 1 | 2004 | 5 | 0.050 |
Why?
|
| Calbindin 1 | 1 | 2004 | 8 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2004 | 38 | 0.050 |
Why?
|
| Duodenum | 1 | 2005 | 112 | 0.050 |
Why?
|
| Parathyroid Glands | 1 | 2004 | 77 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 239 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2004 | 76 | 0.050 |
Why?
|
| Glutathione | 1 | 2004 | 108 | 0.050 |
Why?
|
| Peptides | 1 | 2007 | 669 | 0.050 |
Why?
|
| Chromatin | 1 | 2007 | 454 | 0.050 |
Why?
|
| Cell Movement | 1 | 2007 | 814 | 0.050 |
Why?
|
| Eating | 1 | 2004 | 164 | 0.050 |
Why?
|
| Weight Gain | 1 | 2004 | 134 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 126 | 0.050 |
Why?
|
| Submandibular Gland | 1 | 2003 | 18 | 0.050 |
Why?
|
| Biomarkers | 1 | 2010 | 2016 | 0.050 |
Why?
|
| Aldosterone | 1 | 2003 | 57 | 0.050 |
Why?
|
| Sodium, Dietary | 1 | 2002 | 9 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 258 | 0.050 |
Why?
|
| Drinking Behavior | 1 | 2002 | 13 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 581 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 141 | 0.050 |
Why?
|
| Keratin-14 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Hypocalcemia | 1 | 2002 | 43 | 0.050 |
Why?
|
| Keratins | 1 | 2002 | 62 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 419 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2002 | 113 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2006 | 384 | 0.040 |
Why?
|
| Transgenes | 1 | 2002 | 173 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 328 | 0.040 |
Why?
|
| DNA | 1 | 2007 | 1274 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2007 | 1004 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 267 | 0.040 |
Why?
|
| Water | 1 | 2003 | 310 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 700 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 291 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 945 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 556 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 780 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 1208 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2002 | 446 | 0.040 |
Why?
|
| Mutation | 1 | 2011 | 4389 | 0.040 |
Why?
|
| Liver | 1 | 2004 | 1231 | 0.040 |
Why?
|
| Skin | 1 | 2002 | 592 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1814 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 9689 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2016 | 93 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 84 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 161 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2014 | 50 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 51 | 0.030 |
Why?
|
| Adenoma | 1 | 2016 | 260 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 285 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1028 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 301 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 448 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 369 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 518 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 720 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1995 | 0.020 |
Why?
|
| Microvilli | 1 | 2009 | 44 | 0.020 |
Why?
|
| Ion Transport | 1 | 2009 | 86 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1787 | 0.020 |
Why?
|
| Exocytosis | 1 | 2009 | 109 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 276 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2009 | 122 | 0.020 |
Why?
|
| Azo Compounds | 1 | 2008 | 14 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 36 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 128 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 102 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 21 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 102 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 92 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 125 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 159 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 212 | 0.010 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 135 | 0.010 |
Why?
|
| Cell Division | 1 | 2007 | 689 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 358 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 21703 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1565 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 29366 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2884 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 1757 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 29498 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 7371 | 0.010 |
Why?
|